Business · 05/01/2000Updated: 10/17/2026 · 1 min read
FDA Announces Year 2000 Meetings of Clinical Hold Oversight Committee for Review of Investigational Biological Product Trials
Summary
The FDA is inviting biological product companies to submit investigational biological product trials on clinical hold for review by its oversight committee, following a 12-month review period
Original source language: Federal Register — Food and Drug AdministrationOpen original release →